Brief: Reata Pharmaceuticals To Report Q3 2022 Results On Nov 8
31/10/2022 21:15
Oct 31 (Reuters) - Reata Pharmaceuticals Inc RETA.O :
* REATA PHARMACEUTICALS, INC. TO REPORT THIRD QUARTER 2022
FINANCIAL RESULTS AND TO PROVIDE AN UPDATE ON CLINICAL
DEVELOPMENT PROGRAMS ON NOVEMBER 8, 2022
Source text for Eikon: ID:nBwtX6d4a
Further company coverage: RETA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reata Pharmaceuticals
See all newsReata Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Reata Pharmaceuticals Inc expected to post a loss of $2.88 a share - Earnings Preview
Brief: Biogen Inc Says If Deal Terminated Under Certain Conditions, Reata Will Be Required To Pay Biogen Termination Fee Equal To $264 Mln
U.S. STOCKS ON THE MOVE-US regional banks, Enphase, Centene
Biogen’s $7 bln deal goes smaller and safer